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FOR COMMONLY USED MEDICATIONS
IN GASTROINTESTINAL CANCER
M.A. Frouws
1.  The benefi cial effect on survival in cancer patients must be 
explained by a unique feature in the working mechanism 
of aspirin other than the inhibition of aggregation of 
thrombocytes. (this thesis)
2.  In the hierarchy of evidence, randomised controlled trials 
are the highest and therefore aspirin should not be used 
as adjuvant therapy before testing its effect on survival in 
randomised fashion. (this thesis)
3.  Further observational studies in the fi eld of aspirin and cancer 
will not augment the evidence. (this thesis)
4.  The working mechanism of aspirin will not be unravelled with 
single biomarkers. (this thesis)
5.  Future studies on the working mechanism of aspirin must 
focus on gene expression molecular subtyping of colorectal 
cancer. 
6.  Collaboration is the new competition in cancer research. 
7.  Drug repurposing in cancer treatment must be granted more 
priority by funding organisations, otherwise many valuable 
new treatment options will remain underdeveloped.
8.  Twenty-fi rst century doctors should have management 
competencies and knowledge of healthcare organisation to 
take part in the debate about increasing healthcare costs.
9.  All biologists know that variation itself is nature’s only 
irreducible essence. 
(The Median Isn’t the Message, Stephen Jay Gould, 1992)
10.  If you think adventure is dangerous, try routine, 
it’s lethal. (Paulo Coelho on Twitter, 2011)
